Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Bupivacaine in TAP Block
NCT05244252Phase 1Unknown
- Sponsor
- Sheikh Zayed Medical College
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Sheikh Zayed Medical College. Primary endpoint: Visual Analogue Scale at 12 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05244252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05244252.